Skip to main content
Top
Published in: Neurological Sciences 7/2020

01-07-2020 | Parkinson's Disease | Brief Communication

Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson’s disease in clinical middle stages

Authors: Jiang Huang, Qingping Wang, Kai Li, Qin Zhang, Guoxu Xu, Jing Liu, Ji Zhang, Tongtong Niu, Qilin Zhang, Weifeng Luo

Published in: Neurological Sciences | Issue 7/2020

Login to get access

Abstract

Background

The retinal morphological change has been detected in Parkinson’s disease. However, the previous studies had a controversial conclusion. The aim of this study was to observe the changes of retinal morphology in patients with Parkinson’s disease with different clinical stages based on Hoehn-Yahr stage by spectral domain optical coherence tomography (SD-OCT).

Method

Fifty-three PD patients and forty-one healthy controls (HC) were enrolled. Subjects were assessed for the retinal structure using SD-OCT and general ophthalmic examinations. The PD group was divided into three subgroups by the Hoehn and Yahr scale: H-Y I stage group, H-Y II stage group, and H-Y III stage group.

Results

The mean deviation of visual field had a significant difference among the four groups. The macular retinal thickness (MRT) and macular volume (MV) were obviously decreased in PD patients. And the further statistical analysis showed that the difference appeared between the H-Y III stage group and HC group. The other subgroups had no differences compared with the HC group.

Conclusion

SD-OCT examination can detect the changes in retinal morphology in PD patients, and it may not be found the difference until the patients are in the H-Y III stage (the middle stage of PD).
Literature
2.
go back to reference Bodiswollner I, Kozlowski P, Glazman S, Miri S (2014) α-Synuclein in the inner retina in parkinson disease. Ann Neurol 75(6):964–966CrossRef Bodiswollner I, Kozlowski P, Glazman S, Miri S (2014) α-Synuclein in the inner retina in parkinson disease. Ann Neurol 75(6):964–966CrossRef
4.
go back to reference Huang J, Li Y, Xiao J, Zhang Q, Xu G, Wu G, Liu T, Luo W (2018) Combination of multifocal electroretinogram and spectral-domain OCT can increase diagnostic efficacy of Parkinson’s disease. J Park Dis 2018:1–7 Huang J, Li Y, Xiao J, Zhang Q, Xu G, Wu G, Liu T, Luo W (2018) Combination of multifocal electroretinogram and spectral-domain OCT can increase diagnostic efficacy of Parkinson’s disease. J Park Dis 2018:1–7
5.
go back to reference Sari ES, Koc R, Yazici A, Sahin G, Ermis SS (2014) Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. J Neuroophthalmol 35(2):117 Sari ES, Koc R, Yazici A, Sahin G, Ermis SS (2014) Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. J Neuroophthalmol 35(2):117
7.
go back to reference Tsironi EE, Dastiridou A, Katsanos A, Dardiotis E, Veliki S, Patramani G, Zacharaki F, Ralli S, Hadjigeorgiou GM (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12(1):54–54CrossRefPubMedPubMedCentral Tsironi EE, Dastiridou A, Katsanos A, Dardiotis E, Veliki S, Patramani G, Zacharaki F, Ralli S, Hadjigeorgiou GM (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol 12(1):54–54CrossRefPubMedPubMedCentral
8.
go back to reference Unlu M, Sevim DG, Gultekin M, Karaca C (2018) Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson’s disease. Neurol Sci 39(3):533–541CrossRefPubMed Unlu M, Sevim DG, Gultekin M, Karaca C (2018) Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson’s disease. Neurol Sci 39(3):533–541CrossRefPubMed
9.
go back to reference Garciamartin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470–478CrossRef Garciamartin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470–478CrossRef
10.
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRefPubMedPubMedCentral Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRefPubMedPubMedCentral
Metadata
Title
Spectral domain OCT can differentiate the retinal morphological changes of patients with Parkinson’s disease in clinical middle stages
Authors
Jiang Huang
Qingping Wang
Kai Li
Qin Zhang
Guoxu Xu
Jing Liu
Ji Zhang
Tongtong Niu
Qilin Zhang
Weifeng Luo
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 7/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04266-z

Other articles of this Issue 7/2020

Neurological Sciences 7/2020 Go to the issue